The NOL® Index technology has become the sole device to receive both CE and FDA approval for assessing pain levels in anaesthetized patients undergoing surgery. Analgesia safety for patient safety. The NOL® Index technology noninvasively quantifies the physiological pain response (nociception) in critical care settings, enabling you to provide a personalized pain treatment according to your patient's anaesthetic needs.
The NOL® Index has been proven to:
• Help reduce postoperative pain by 33%
• Reduce intraoperative opioids usage (remifentanil) by 30%
• Reduce the probability of postoperative complications
• Reduce intraoperative hypotensive events by 80%
We offer free trials!
Contact us and our reps will get in touch with you as soon as possible to arrange for the free trial.
Managing nociception during surgery is a major challenge, impacting patient outcomes, length of stay and cost of treatment.
Excessive use of opioids may result in intraoperative hypotension, respiratory depression, PONV etc.,1,2,3 and underuse of analgesics may promote acute or chronic post-operative pain, delayed recovery and the costs associated with these complications.4,5,6
The PMD-200TM nociception monitor, developed by Medasense Ltd., helps you monitor your anaesthetized patients' physiological pain response (nociception) to noxious stimuli and tailor analgesic medications to each patient’s specific sensitivity and needs. The integrated nociception level index (NOL®) provides superior indication of the presence and severity of pain response vs. individual parameters (such as changes in heart rate and blood pressure) to reduce complications and improve patient outcomes.7,8
1. ACQUIRE → 2. ANALYZE → 3. QUANTIFY → 4. OPTIMAL PAIN CARE
The non-invasive platform continuously acquires physicological signals through 4 sensors. Dozens of physiological parameters and derivatives are extracted
Advanced articificial intelligence algorithms identify the pain-related pattern
The information is quantified and visualized with the NOL® index on a scale of 0 (no nociceptive response) to 100 (extreme nociceptive response)
NOL® guides clinicians to ensure optimal pain control while avoiding overmedication
By optimizing analgesic administration in critical care, NOL®-guided analgesia might enhance the patient experience as it reduces the risk of excessive use or underuse of opioids and associated complications.9